Try our Advanced Search for more refined results

Cherokee Nation v. CVS Pharmacy, Inc. et al.

  1. September 06, 2022

    Pharmacies Flooded NM With Opioids, AG Says As Trial Starts

    New Mexico's attorney general launched an opioid-crisis trial on Tuesday against three pharmacy giants with a comparison of stewardship of drugs to that of water in his arid state, saying reckless opioid dispensing by Walgreens, Walmart and Kroger "smashed those dams wide open."

  2. March 28, 2022

    Pharmacies Ask 10th Circ. To Stop Cherokee Opioid Suit Move

    Three national pharmacy chains accused of contributing to rampant opioid addiction on the Cherokee Nation reservation in northeastern Oklahoma have asked the Tenth Circuit to keep the tribe's multidistrict bellwether suit out of state court, where it was recently remanded.

  3. March 23, 2022

    Cherokee Opioid Bellwether Suit Is Moved To State Court

    A federal judge has remanded to Oklahoma state court the Cherokee Nation's opioid-abuse lawsuit against a trio of national pharmacy chains, finding that he no longer has jurisdiction after several drug distributors were tossed from the case last year as part of their settlement with the tribe.

  4. March 11, 2022

    Key Opioid Cases To Watch As Massive Wave Of Trials Looms

    Despite sweeping settlements and landmark verdicts, the nation's epic saga of opioid crisis litigation against Big Pharma is far from winding down, with the coming weeks heralding an unprecedented torrent of trials. Here, Law360 shares a detailed map of the opioid trials terrain and explores major lawsuits that are rapidly approaching moments of truth.

  5. February 01, 2022

    Tribes Reach $590M Opioids Deal With J&J, Distributors

    Native American tribes have agreed to a deal worth nearly $590 million with Johnson & Johnson and major opioid distributors to settle claims over the companies' alleged role in exacerbating the opioid crisis, according to court filings Tuesday.

  6. January 18, 2022

    Tribe Says Its Opioid Suit Was Not Harmed By Dropped Claim

    The Cherokee Nation's negligence and conspiracy claims against Walmart, Walgreens and CVS pharmacies over their role in the opioid crisis should proceed even though it dropped public nuisance claims, the tribe told an Oklahoma federal judge overseeing a bellwether case in multidistrict litigation. 

  7. January 11, 2022

    Cherokees Drop 'Public Nuisance' Theory In Opioid Bellwether

    The Cherokee Nation said it was no longer going to pursue its public nuisance theory of liability against major pharmacy chains in a tribal bellwether case in multidistrict opioid litigation.

  8. January 03, 2022

    A Blockbuster Year Ahead For Health, Life Sciences Litigation

    Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.

  9. November 04, 2021

    Cherokee Nation Bashes Pharmacies' Prescription Data Bid

    The Cherokee Nation in its massive opioid suit against big pharmacy companies has slammed their attempt in Oklahoma federal district court to force the tribe to identify the names of all citizens on the Cherokee Register to determine who filled prescriptions, arguing the companies' request is unprecedented.

  10. October 28, 2021

    Walgreens, CVS Eye Prescription Data In Tribe's Opioid Row

    Walgreens and CVS have asked an Oklahoma federal judge to help them see a confidential database of state prescriptions in an opioid battle with the Cherokee Nation, arguing that the data could prove that they didn't push out more opioids than other providers that weren't sued.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!